-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 SgNUm5OcWrrQRJYtYITfnqmEypX9EihlObmvBJphrHK97atHcjo/6DNS58RVbrs1
 i091tSyUpJ1oLDFwv9hZDg==

<SEC-DOCUMENT>0001181431-09-057797.txt : 20091218
<SEC-HEADER>0001181431-09-057797.hdr.sgml : 20091218
<ACCEPTANCE-DATETIME>20091218165741
ACCESSION NUMBER:		0001181431-09-057797
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20091209
FILED AS OF DATE:		20091218
DATE AS OF CHANGE:		20091218

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Stalar 3 Inc.
		CENTRAL INDEX KEY:			0001419983
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		IRS NUMBER:				261402659
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		317 MADISON AVE.
		STREET 2:		SUITE 1520
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		(212) 953-1544

	MAIL ADDRESS:	
		STREET 1:		317 MADISON AVE.
		STREET 2:		SUITE 1520
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Abraxis BioScience, Inc.
		CENTRAL INDEX KEY:			0001409012
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-52973
		FILM NUMBER:		091250663

	BUSINESS ADDRESS:	
		STREET 1:		11755 WILSHIRE BLVD., 20TH FLOOR
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		310-883-1300

	MAIL ADDRESS:	
		STREET 1:		11755 WILSHIRE BLVD., 20TH FLOOR
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER NAME:	
		FORMER CONFORMED NAME:	Abraxis Biosciences, Inc.
		DATE OF NAME CHANGE:	20071120

	FORMER NAME:	
		FORMER CONFORMED NAME:	New Abraxis, Inc.
		DATE OF NAME CHANGE:	20070806

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Abraxis BioScience, LLC
		CENTRAL INDEX KEY:			0001450648
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-52973
		FILM NUMBER:		091250664

	BUSINESS ADDRESS:	
		STREET 1:		11755 WILSHIRE BLVD., 20TH FLOOR
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		310-883-1300

	MAIL ADDRESS:	
		STREET 1:		11755 WILSHIRE BLVD., 20TH FLOOR
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>rrd260447.xml
<DESCRIPTION>INITAL FILING
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0203</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2009-12-09</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001419983</issuerCik>
        <issuerName>Stalar 3 Inc.</issuerName>
        <issuerTradingSymbol>NONE</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001450648</rptOwnerCik>
            <rptOwnerName>Abraxis BioScience, LLC</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>11755 WILSHIRE BOULEVARD, SUITE 2000</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>LOS ANGELES</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>90025</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001409012</rptOwnerCik>
            <rptOwnerName>Abraxis BioScience, Inc.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>11755 WILSHIRE BOULEVARD, SUITE 2000</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>LOS ANGELES</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>90025</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>2022500</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                    <footnoteId id="F1"/>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">The shares of common stock are owned directly by Abraxis BioScience, LLC, which is a wholly-owned subsidiary of Abraxis BioScience, Inc.  Abraxis BioScience, Inc. is an indirect beneficial owner of the reported securities.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Bruce Wendel</signatureName>
        <signatureDate>2009-12-18</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----